G9a overexpression enhances H3K9me2 deposition, silencing and inhibiting tumor suppressor genes, and promoting tumor proliferation and migration through the Wnt pathway and epithelial-to-mesenchymal transformation (EMT), which can be a useful target for anticancer therapy (65). This evidence concerns the gene EHMT2 and neoplasm.